Abiopharma

Subsequently, Wellington Management Group LLP informed us that, as of June 16, 2022 Wellington Management Group LLP had increased their holding of shares in Genmab AS to 5. 99% of the share capital and voting rights in Genmab AS, so that through shares and financial instruments they held the voting rights to 3,293,871 shares in Genmab AS, which amounts to 5. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer.